Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
275
-
Total 13F shares, excl. options
-
61.9M
-
Shares change
-
+1.5M
-
Total reported value, excl. options
-
$2.96B
-
Value change
-
+$41.6M
-
Put/Call ratio
-
1.2
-
Number of buys
-
134
-
Number of sells
-
-176
-
Price
-
$47.85
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q3 2022
368 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q3 2022.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 275 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.9M shares
of 66.6M outstanding shares and own 92.96% of the company stock.
Largest 10 shareholders include FMR LLC (8.97M shares), VANGUARD GROUP INC (6.19M shares), BlackRock Inc. (6.09M shares), Capital World Investors (4.56M shares), Champlain Investment Partners, LLC (3.12M shares), BROWN CAPITAL MANAGEMENT LLC (2.01M shares), STATE STREET CORP (1.78M shares), EMINENCE CAPITAL, LP (1.59M shares), Bellevue Group AG (1.57M shares), and Invesco Ltd. (1.23M shares).
This table shows the top 275 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.